Vir Biotechnology, Inc. (VIR) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 835.28M |
| Enterprise Value | 788.08M |
| P/E Ratio | -5.29 |
| PEG Ratio | -0.07 |
| Price/Sales Ratio | 5.44 |
| Price/Book Ratio | 1.67 |
| Enterprise/Revenue | 4.83 |
| Enterprise/EBITDA | -5.99 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -0.83 |
| Operating Margin | -0.89 |
| Return On Assets | -0.21 |
| Return On Equity | -0.3 |
| Revenue | 68.56M |
| Revenue/Share | 1.81 |
| Gross Profit | 56.85M |
| EBITDA | -426.09M |
| Net Income | -437.99M |
| Diluted EPS | -3.16 |
| Total Cash | 528.59M |
| Total Cash/Share | 3.15 |
| Total Debt | 93.27M |
| Total Debt/Equity | 0.09 |
| Current Ratio | 6.04 |
| Book Value Per Share | 5.86 |
| 52-Week Change | 123.29 |
| 52-Week High | 11.66 |
| 52-Week Low | 4.35 |
| Moving Average 50 Days | 9.37 |
| Moving Average 200 Days | 8.3 |
| Average Volume | 1.84M |
| Shares Outstanding | 168.65M |
| % Held by Institutions | 100.3 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |